Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 08:34 am Purchase |
2025-03-31 | 13G | Tenax Therapeutics, Inc. TENX |
RTW INVESTMENTS LP | 418,440 9.990% |
418,440 (New Position) |
Filing History |
| 2025-05-15 08:29 am Sale |
2025-03-31 | 13G | 89bio, Inc. ETNB |
RTW INVESTMENTS LP | 1,967,527 1.300% |
-5,411,021 (-73.33%) |
Filing History |
| 2025-05-15 08:26 am Purchase |
2025-03-31 | 13G | GH Research PLC GHRS |
RTW INVESTMENTS LP | 5,499,769 8.900% |
2,172,640 (+65.30%) |
Filing History |
| 2025-05-15 08:22 am Sale |
2025-03-31 | 13G | PepGen Inc. PEPG |
RTW INVESTMENTS LP | 0 0.000% |
-3,193,097 (Position Closed) |
Filing History |
| 2025-05-15 08:17 am Sale |
2025-03-31 | 13G | Dyne Therapeutics, Inc. DYN |
RTW INVESTMENTS LP | 1,690,567 1.500% |
-3,528,074 (-67.61%) |
Filing History |
| 2025-05-15 08:15 am Purchase |
2025-03-31 | 13G | Beta Bionics, Inc. BBNX |
RTW INVESTMENTS LP | 3,299,869 7.600% |
3,299,869 (New Position) |
Filing History |
| 2025-05-15 08:09 am Sale |
2025-03-31 | 13G | Axsome Therapeutics, Inc. AXSM |
RTW INVESTMENTS LP | 2,922,729 6.000% |
-1,128,636 (-27.86%) |
Filing History |
| 2025-05-15 08:07 am Purchase |
2025-03-31 | 13G | Verastem, Inc. VSTM |
RTW INVESTMENTS LP | 4,245,476 8.300% |
4,245,476 (New Position) |
Filing History |
| 2025-05-15 08:00 am Sale |
2025-03-31 | 13G | Immunic, Inc. IMUX |
RTW INVESTMENTS LP | 1,026,762 1.100% |
-4,567,717 (-81.65%) |
Filing History |
| 2025-05-15 08:00 am Purchase |
2025-03-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
RTW INVESTMENTS LP | 20,673,307 9.990% |
8,304,973 (+67.15%) |
Filing History |
| 2025-05-15 08:00 am Purchase |
2025-03-31 | 13G | Oruka Therapeutics, Inc. ORKA |
RTW INVESTMENTS LP | 1,945,649 5.200% |
1,945,649 (New Position) |
Filing History |
| 2025-05-15 08:00 am Purchase |
2025-03-31 | 13G | COMPASS Pathways plc CMPS |
RTW INVESTMENTS LP | 7,877,349 8.300% |
7,877,349 (New Position) |
Filing History |
| 2025-05-15 08:00 am Purchase |
2025-03-31 | 13G | uniQure N.V. QURE |
RTW INVESTMENTS LP | 4,265,428 7.900% |
4,265,428 (New Position) |
Filing History |
| 2025-05-15 08:00 am Purchase |
2025-03-31 | 13G | RAPT Therapeutics, Inc. RAPT |
RTW INVESTMENTS LP | 11,764,000 8.900% |
11,764,000 (New Position) |
Filing History |
| 2025-05-01 5:41 pm Purchase |
2025-04-29 | 13D | Orchestra BioMed Holdings, Inc. OBIO |
RTW INVESTMENTS LP | 8,306,063 21.700% |
602,033 (+7.81%) |
Filing History |
| 2025-04-17 6:34 pm Purchase |
2025-04-15 | 13D | Allurion Technologies Inc. ALUR |
RTW INVESTMENTS LP | 2,542,603 34.100% |
1,492,550 (+142.14%) |
Filing History |
| 2025-02-24 4:15 pm Purchase |
2025-02-20 | 13D | Allurion Technologies Inc. ALUR |
RTW INVESTMENTS LP | 1,050,053 17.600% |
903,389 (+615.96%) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
RTW INVESTMENTS LP | 6,859,823 9.800% |
940,388 (+15.89%) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW INVESTMENTS LP | 5,310,033 9.990% |
1,178,988 (+28.54%) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Establishment Labs Holdings Inc. ESTA |
RTW INVESTMENTS LP | 2,822,216 9.990% |
328,078 (+13.15%) |
Filing History |